Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia

Juvenile dermatomyositis (JDM) is characterized by proximal muscle weakness, vasculopathy of the skin and muscles, and typical skin rash. Approximately, 70% of adult patients with dermatomyositis have evidence of cardiac damage. However, cardiac involvement, one of the important causes of death, has...

Full description

Saved in:
Bibliographic Details
Published inRheumatology international Vol. 27; no. 2; pp. 179 - 182
Main Authors Karaca, Neslihan Edeer, Aksu, Guzide, Yeniay, Betul Sozeri, Kutukculer, Necil
Format Journal Article
LanguageEnglish
Published Germany Springer Nature B.V 01.12.2006
Subjects
Antirheumatic Agents - therapeutic use
Bradycardia - drug therapy
Bradycardia - etiology
Cardiac arrhythmia
Child
Dermatomyositis - complications
Dermatomyositis - drug therapy
Humans
Immunoglobulins, Intravenous - therapeutic use
Immunologic Factors - therapeutic use
Male
Methotrexate - therapeutic use
Methylprednisolone - therapeutic use
Sinoatrial Node - drug effects
Sinoatrial Node - physiopathology
Online AccessGet full text

Cover

More Information
Summary:Juvenile dermatomyositis (JDM) is characterized by proximal muscle weakness, vasculopathy of the skin and muscles, and typical skin rash. Approximately, 70% of adult patients with dermatomyositis have evidence of cardiac damage. However, cardiac involvement, one of the important causes of death, has been reported rarely in children with JDM. Here, we describe an 11-year-old boy who presented with bradycardia as a result of sinus node involvement due to JDM and recovered by the treatment of JDM without any specific drug for bradycardia.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0172-8172
1437-160X
DOI:10.1007/s00296-006-0191-7